Research area
Parkinson's Disease medication trials
You can ask CNS Medication Trials whether a Parkinson's disease study may be a fit for you. Research in this area looks at investigational medications, devices, and exercise or therapy programs for movement and non-movement symptoms.
Updated
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Parkinson's disease medication studies in numbers
- Parkinson's disease medication studies recruiting in the U.S.
- 73
- states with a study site
- 49
- studies that accept healthy volunteers
- 21
Source: ClinicalTrials.gov. Data processed .
Find Parkinson's disease medication studies by state
These states have the most studies recruiting right now.
California
25 studies recruiting.
Texas
25 studies recruiting.
Florida
24 studies recruiting.
Michigan
20 studies recruiting.
Pennsylvania
20 studies recruiting.
New York
18 studies recruiting.
Parkinson's disease medication studies recruiting now
As of November 17, 2026, 73 Parkinson's disease medication studies are recruiting participants in the United States, according to ClinicalTrials.gov. This site lists only studies that test a medication, as each study is coded in the registry. This is what they have in common.
What they test
- medications73
- biologics such as vaccines or antibodies14
- other approaches6
- behavioral approaches such as talk therapy or training4
- diagnostic tests4
A study can test more than one.
Main purpose
- treating a condition48
- diagnosis15
- basic science7
- prevention2
Phase
- Early Phase 17
- Phase 110
- Phase 1/210
- Phase 224
- Phase 2/32
- Phase 310
- Phase 49
- No phase1
Studies of devices and behavioral approaches have no phase.
Who runs them
- industry39
- university, hospital or other29
- government5
Who they enroll
- adults (18 to 64)73
- older adults (65 and over)72
21 also accept healthy volunteers.
These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.
Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 73 studies.
Recently updated Parkinson's disease medication studies
The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Aurora, CO · Bethlehem, PA · Boston, MA · and 41 more U.S. locations
- Registry record
- NCT06623422 · updated
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Albuquerque, NM · Altamonte Springs, FL · Athens, GA · and 30 more U.S. locations
- Registry record
- NCT06841354 · updated
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- Phase 3
- Ages 18 and older
- Female participants
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Albuquerque, NM · Anchorage, AK · Bethlehem, PA · and 47 more U.S. locations
- Registry record
- NCT06952504 · updated
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Altamonte Springs, FL · Baltimore, MD · Boston, MA · and 53 more U.S. locations
- Registry record
- NCT06966700 · updated
18F-mFBG Cardiac Uptake With Lewy Body Dementia
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)
- Recruiting in
- Houston, TX
- Registry record
- NCT07176286 · updated
Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease
- Phase 4
- Ages 18 and older
- All sexes
- Sponsor
- VA Office of Research and Development
- Recruiting in
- Decatur, GA
- Registry record
- NCT07187466 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in the United States on ClinicalTrials.gov.
What Parkinson's disease studies look at
When you look into a Parkinson's disease study through CNS Medication Trials, you will find that it was built to answer one specific question. That question shapes what you would be asked to do, so the tasks change from one study to the next. Across this area of research, studies examine investigational medications, devices, and exercise or therapy programs for movement and non-movement symptoms.
Whatever a study is testing is investigational. Researchers are still learning how well it works and what its risks are. The study exists to find that out.
Who may be able to take part
At a screening visit, the study team for a CNS medication trial checks whether you fit that study's requirements, so you are not expected to figure this out alone. Requirements differ from one study to the next. How old you are can matter. So can your medical background, whatever medicines you are currently on, and the way a condition affects you. People without the condition are enrolled in certain studies too.
What taking part usually involves
A first conversation
First you talk with a coordinator, who gives you a broad outline of the CNS medication trial. Nothing further happens until whatever you want to ask has been answered.
Informed consent
A written document then comes to you from the study team. It sets out everything about the trial, with the risks that are known included. Whether to agree is your decision.
Screening
Next, the study team asks about your health and carries out some tests. The answers and results tell them whether this CNS medication trial suits you. Some people complete this step and are not enrolled afterward.
Study visits
Should you join, your visits are planned in advance, and at each one the study team looks at how your health is doing. Stopping is your call. You may step away from the trial at any point.
Questions about Parkinson's disease medication studies
Do I need a diagnosis to join a study about Parkinson's disease?
You will hear from the study team which rule covers your situation, because it differs between CNS medication trials. A confirmed diagnosis is required for some. In others, the assessment takes place as part of screening.
Would I have to change the care I receive now?
You will go through this with the study doctor, since certain studies let your current care continue while others do not. You are also welcome to discuss it with your regular doctor ahead of any decision. Whatever you decide, do not alter your care by yourself.
Is there a cost to take part?
The visits, tests and medication that belong to a CNS medication trial typically come at no charge to you when you take part. Our guide to costs explains more.
Ask about Parkinson's disease medication studies
Send us a little information and expect to hear back from a coordinator about CNS medication trials. Making an enquiry carries no obligation of any kind.
Independent information
- Parkinson's Disease — National Institute of Neurological Disorders and Stroke (NIH)
- Clinical Trials — MedlinePlus (National Library of Medicine)
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)